Federal drug pricing policy is evolving at an extraordinary pace. With implementation of the Inflation Reduction Act (IRA) well underway and the recent announcements of new Center for

Immunology is shaping one of the most dynamic areas of modern medicine. From autoimmune and inflammatory diseases – like atopic dermatitis, ulcerative colitis and Crohn’s

Advancing health policies that improve outcomes and meet the moment requires careful leadership and collaboration. The journey from identifying an issue that needs to be

For more than two decades, the dominant paradigm for explaining pharmaceutical pricing has been value. That value was defined by clinical benefit, improved patient outcomes or experience, and

November 2025 may ultimately be remembered as a pivotal moment in how the United States understands and treats obesity. Last month, federal regulators announced an

A new election cycle is upon us, which means America is once again scrolling its way through headlines, policy debates, and an endless stream of